License Agreements


  • *Sanofi, MannKind aim to launch Afrezza in U.S. in Q1 2015. PARIS/ LONDON, Aug 11- French drugmaker Sanofi is betting on inhaled insulin as an alternative option to daily injections for diabetics by signing a worldwide licensing agreement with MannKind Corp worth up to $925 million.

  • LONDON, July 22- ARM Holdings, the British company whose processor designs power Apple's and Samsung's smartphones, posted a 9 percent rise in second-quarter profit, helped by strong demand to license its technology.